rpsgl-ig
Recombinant proteinexperimental
Clinical trial activity
2 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started May 1, 2006 (NCT00298168)
Timeline
Indications
Mechanism of action
- P-selectin glycoprotein ligand 1INHIBITOR
SELPLG inhibitor
Chemistry & pharmacology
- Multi-specific
- No
Oral
No
Parenteral
No
Topical
No
Also known as
- rpsgl-ig
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00450398 | Phase 2 | Mar 1, 2007 | Y's Therapeutics, Inc. |
| NCT00298168 | Phase 1/Phase 2 (Phase 2) | May 1, 2006 | Y's Therapeutics, Inc. |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Y's Therapeutics, Inc. | For profit | 2 | 2 | 1 | 2006 |
1 organizations
Page 1 / 1